Related Experiment Video
Updated: May 14, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Development of icterus gravis in a preterm infant with G71R UGT1A1 polymorphism
Akimune Kaga1, Yukimune Ohkubo, Yohei Watanabe
1Department of Pediatrics, Hachinohe City Hospital, 1 Bisyamontaira, Hachinohe, Aomori, 031-8555, Japan. kagakimune@yahoo.co.jp
Insights
The G71R polymorphism in the UGT1A1 gene is linked to severe jaundice in very low birth weight infants (VLBWIs). This finding highlights the need for careful monitoring and management of jaundice in these vulnerable infants.
Area of Science:
- Genetics
- Neonatology
- Pharmacogenomics
Background:
- The UGT1A1 gene is crucial for bilirubin conjugation in the liver; deficiencies cause jaundice.
- Gilbert's syndrome is linked to UGT1A1 polymorphisms like G71R, typically seen in term infants.
- The G71R polymorphism's role in jaundice in very low birth weight infants (VLBWIs) remained unstudied.
Observation:
- A preterm infant (28 weeks, 1172g) developed severe jaundice (total bilirubin 23.7 mg/dL) on day 21.
- Genetic analysis revealed the infant was heterozygous for the G71R polymorphism in the UGT1A1 gene.
- Other causes of jaundice, including blood incompatibility and metabolic disorders, were ruled out.
Findings:
- The G71R polymorphism was identified in a VLBWI presenting with severe jaundice.
- This suggests reduced UGT1A1 activity in the infant, contributing to hyperbilirubinemia.
- Breastfeeding and medications were speculated as potential triggers for jaundice in this infant.
Implications:
- The G71R polymorphism may be present in VLBWIs, increasing their risk for severe jaundice.
- This necessitates vigilant monitoring for jaundice in VLBWIs carrying this genetic variant.
- Early identification and management of severe jaundice are critical for improved outcomes in preterm infants.
Background:
Uridine diphosphate-glucuronosyltransferase (UGT) gene family is involved in the detoxification of biomaterials and drugs in the liver. Among the UGT gene family members, only UGT1A1 is involved in bilirubin conjugation. As a result, deficient UGT1A1 activity causes jaundice. One disease that is characterized by reduced UGT1A1 activity is Gilbert's syndrome. Two prevalent UGT1A1 polymorphisms responsible for Gilbert's syndrome have been identified: G71R in exon 1 and A(TA)7TAA in the TATA box of the promoter region. Recently, the G71R polymorphism has been associated with breastfeeding jaundice and neonatal hyperbilirubinemia in term infants. However, its association with jaundice in very low birth weight infants (VLBWIs) has never been reported.
Case Presentation:
The patient was a female born at 28 weeks, 4 days gestation with a birth weight of 1172 g. On day 21, intense yellowing of the skin and eyes was noted, and the patient's total bilirubin level was 23.7 mg/dL (her direct bilirubin level was 2.1 mg/dL). Therefore, an exchange transfusion was conducted. She had neither blood type incompatibility nor a family history of constitutional jaundice. Metabolic screens for amino and organic acids were negative. No elevation of any of the examined antibody titers was noted, and no evidence of an inflammatory reaction was observed. In addition, no hematological abnormalities were detected. The direct/indirect Coombs test, irregular antibody test and red blood cell antibody dissociation test were all negative, and her thyroid function was normal. We performed sequence analysis of the UGT1A1 gene after the patient's parents provided written informed consent. Exon 1 of the UGT1 gene on chromosome 2 was analyzed by direct sequencing. A heterozygous substitution from G to A (211G→A: G71R) in base 211 was noted.
Conclusion:
We speculated that this preterm infant with carrying the G71R polymorphism reduced UGT1A1 activity and developed severe jaundice that was likely triggered by factors such as breast feeding and medications. The polymorphism appears at some frequency among VLBWIs, which would necessitate adequate care of severe jaundice even after the acute phase.
Related Concept Videos
Jaundice
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
